Furthermore, cGAS-STING agonists stimulate the secretion of the chemokine CXCL10 in an IFN-I-dependent manner [44], which facilitates the recruitment of antigen-specific CD8+ T cells to infiltrate into the tumor and elicit an effective antitumor immune response [33]. The gene discussed is STING1; the disease is neoplasm.